Association Between Homologous Recombination Repair Biomarkers and Survival in Patients With Solid TumorsChangxia Shao, Wei Zhou, Yixin Ren et al.|JCO Precision Oncology|2023Cited by 3
Prevalence of homologous recombination biomarkers in multiple tumor types: an observational studyChen Cai, Changxia Shao, Elisha J. Dettman et al.|Future Oncology|2024Cited by 2
601P Pembrolizumab in patients of Chinese descent with microsatellite instability-high/mismatch repair deficient advanced solid tumors: KEYNOTE-158Xuan Wu, Jing Xu, Jianfeng Yang et al.|Annals of Oncology|2023Cited by 1
Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database StudyChangxia Shao, Wei Zhou, Heng Zhou et al.|Advances in Therapy|2024Cited by 1